These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6539102)

  • 1. Penicillamine-induced pemphigus. Immunoglobulin from this patient induces plasminogen activator synthesis by human epidermal cells in culture: mechanism for acantholysis in pemphigus.
    Hashimoto K; Singer K; Lazarus GS
    Arch Dermatol; 1984 Jun; 120(6):762-4. PubMed ID: 6539102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG.
    Morioka S; Lazarus GS; Jensen PJ
    J Invest Dermatol; 1987 Nov; 89(5):474-7. PubMed ID: 3117905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation.
    Hashimoto K; Shafran KM; Webber PS; Lazarus GS; Singer KH
    J Exp Med; 1983 Jan; 157(1):259-72. PubMed ID: 6681540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional involvement of urokinase-type plasminogen activator receptor in pemphigus acantholysis.
    Xue W; Hashimoto K; Toi Y
    J Cutan Pathol; 1998 Oct; 25(9):469-74. PubMed ID: 9821076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemphigus IgG induces expression of urokinase plasminogen activator receptor on the cell surface of cultured keratinocytes.
    Seishima M; Satoh S; Nojiri M; Osada K; Kitajima Y
    J Invest Dermatol; 1997 Nov; 109(5):650-5. PubMed ID: 9347794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penicillamine-associated pemphigus: is it really pemphigus?
    Troy JL; Silvers DN; Grossman ME; Jaffe IA
    J Am Acad Dermatol; 1981 May; 4(5):547-55. PubMed ID: 7016933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor.
    Hashimoto K; Wun TC; Baird J; Lazarus GS; Jensen PJ
    J Invest Dermatol; 1989 Mar; 92(3):310-4. PubMed ID: 2465356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis.
    Anhalt GJ; Patel HP; Labib RS; Diaz LA; Proud D
    J Immunol; 1986 Jan; 136(1):113-7. PubMed ID: 3079604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of urokinase-type plasminogen activator in the pathogenesis of pemphigus].
    Nie Z; Liu R; Ye Q
    Zhonghua Yi Xue Za Zhi; 1997 Oct; 77(10):771-3. PubMed ID: 9772525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmin induces acantholysis in skin organ cultures.
    Hunziker T; Vassalli JD
    Arch Dermatol Res; 1987; 279(5):341-6. PubMed ID: 2957965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitors prevent plasminogen-mediated, but not pemphigus vulgaris-induced, acantholysis in human epidermis.
    Schuh T; Besch R; Braungart E; Flaig MJ; Douwes K; Sander CA; Magdolen V; Probst C; Wosikowski K; Degitz K
    Biol Chem; 2003 Feb; 384(2):311-5. PubMed ID: 12675525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [D-penicillamine-induced pemphigus: changes in anti-32-2B immunostaining patterns].
    Khashoggi M; Machet L; Perrinaud A; Brive D; Machet MC; Maruani A; Vaillant L
    Ann Dermatol Venereol; 2013; 140(8-9):531-4. PubMed ID: 24034638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro studies of acantholysis of keratinocytes induced by pemphigus antibody.
    Hashimoto KH; Jensen PJ; Lazarus GS; Morioka S; Singer KH
    Immunol Ser; 1989; 46():277-90. PubMed ID: 2535130
    [No Abstract]   [Full Text] [Related]  

  • 14. Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice.
    Mahoney MG; Wang ZH; Stanley JR
    J Invest Dermatol; 1999 Jul; 113(1):22-5. PubMed ID: 10417613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement fixation by pemphigus antibody. IV. Enhanced epidermal cell detachment in the absence of human plasminogen.
    Doubleday CW; Geoghegan WD; Jordon RE
    J Lab Clin Med; 1988 Jan; 111(1):28-34. PubMed ID: 3335823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of plasminogen activator in pemphigus vulgaris.
    Wilkinson JE; Smith CA; Suter MM; Falchek W; Lewis RM
    Am J Pathol; 1989 Mar; 134(3):561-9. PubMed ID: 2466403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of corticosteroids, dapsone and gold upon plasminogen activator synthesis and secretion by human epidermal cells cultured with pemphigus antibody.
    Hashimoto K; Singer K; Lazarus GS
    Br J Dermatol; 1984 Mar; 110(3):293-7. PubMed ID: 6421306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance between plasminogen activator and its inhibitors in thiol-induced acantholysis.
    Lombardi ML; de Angelis E; Rossano F; Ruocco V
    Dermatology; 1993; 186(2):118-22. PubMed ID: 8428039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical findings in a patient with penicillamine pemphigus.
    de Jong MC; Doeglas HM; Dijkstra JW
    Br J Dermatol; 1980 Mar; 102(3):333-7. PubMed ID: 6989386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum.
    Schiltz JR; Michel B
    J Invest Dermatol; 1976 Aug; 67(2):254-60. PubMed ID: 950490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.